Physician

Shaheen Iqbal, MD

According to 2025 Medicare claims, Shaheen Iqbal, MD (NPI: 1194709394) practices pulmonary disease in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Washington, MD. This provider's primary affiliated billing organization is MEDICAL PRACTICES OF ANTIETAM, LLC (NPI: 1558430843; TIN: 522315129) and primary practice location at 21742-2940. Iqbal is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Iqbal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,318 traditional Medicare patients, billed 5,493 HCPCS/CPT codes, and received $330,836 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,340 prescription claims across 355 beneficiaries totaling $933,074 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 5,493 claims. Open Payments data shows 35 records totaling $787. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,250	4,569	$359,564
2016	1,321	4,848	$349,839
2017	1,468	5,086	$381,886
2018	1,469	5,293	$366,823
2019	1,464	5,297	$360,467
2020	1,380	4,572	$318,963
2021	1,207	4,313	$327,395
2022	1,382	4,350	$319,221
2023	1,194	3,818	$276,935
2024	1,318	5,493	$330,836

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	290	1,059	$470,874
2016	312	1,141	$587,238
2017	347	1,231	$670,536
2018	389	1,548	$1,313,101
2019	380	1,525	$1,111,351
2020	372	1,421	$958,880
2021	364	1,422	$913,235
2022	355	1,400	$812,235
2023	387	1,330	$869,175
2024	355	1,340	$933,074

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,878	4,570	$251,241
2016	1,999	5,155	$176,014
2017	2,480	5,948	$144,503
2018	2,638	6,476	$157,365
2019	2,457	6,116	$161,684
2020	2,320	6,076	$205,775
2021	2,216	5,552	$194,572
2022	2,187	4,846	$185,534
2023	2,156	5,073	$204,369
2024	2,172	5,493	$174,836

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	895	1,396	$92
94729	Test to examine how well the lungs exchange gases	369	377	$41
94727	Test to determine lung volumes using gas dilution or washout	369	377	$33
94060	Test to measure expiratory airflow and volume changes before and after medication administration	369	377	$28
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	782	1,131	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	332	22,680	$463,269
Ofev	Nintedanib Esylate	11	330	$144,495
Breo Ellipta	Fluticasone/Vilanterol	122	6,180	$77,744
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	70	3,180	$57,099
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	37	2,160	$31,501

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	187	385	$30,341
E0601	Continuous positive airway pressure (cpap) device	Y	158	949	$26,989
A7031	Face mask interface, replacement for full face mask, each	N	160	412	$23,118
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	153	299	$14,628
A7032	Cushion for use on nasal mask interface, replacement only, each	N	85	215	$12,868

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$787	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shaheen Iqbal, MD?

Tedicare shows public-source Medicare data for Shaheen Iqbal, MD (NPI 1194709394), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shaheen Iqbal, MD have ACO affiliation data?

Shaheen Iqbal, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Shaheen Iqbal, MD?

Shaheen Iqbal, MD is linked to MEDICAL PRACTICES OF ANTIETAM, LLC (billing NPI 1558430843) in the available physician profile data.

Does Shaheen Iqbal, MD have Open Payments data?

Shaheen Iqbal, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.